Theravance Biopharma (TBPH) Return on Capital Employed Growth (1y) (2015 - 2026)
Theravance Biopharma (TBPH) Return on Capital Employed Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | -3,457.00 |
| 10 | Theravance Biopharma | 865.08 Mn | 470.41 Mn | - | 1,611.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,611.00 |
| Dec 31, 2025 | 1,366.00 |
| Sep 30, 2025 | 455.00 |
| Jun 30, 2025 | 93.00 |
| Mar 31, 2025 | -389.00 |
| Dec 31, 2024 | 49.00 |
| Sep 30, 2024 | 350.00 |
| Jun 30, 2024 | 225.00 |
| Mar 31, 2024 | 241.00 |
| Dec 31, 2023 | -102.00 |
| Sep 30, 2023 | 1,451.00 |
| Jun 30, 2023 | 3,938.00 |
| Mar 31, 2023 | 5,186.00 |
| Dec 31, 2022 | 6,403.00 |
| Sep 30, 2022 | 4,832.00 |
| Jun 30, 2022 | 3,604.00 |
| Mar 31, 2022 | 2,594.00 |
| Dec 31, 2021 | 309.00 |
| Sep 30, 2021 | -1,219.00 |
| Jun 30, 2021 | -3,124.00 |